Kalbe Farma

You can help expand this article with text translated from the corresponding article in Indonesian. (January 2024) Click [show] for important translation instructions. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Indonesian Wikipedia article at [[:id:Kalbe Farma]]; see its history for attribution. You may also add the template {{Translated|id|Kalbe Farma}} to the talk page. For more guidance, see Wikipedia:Translation.

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Kalbe Farma" – news · newspapers · books · scholar · JSTOR (September 2012) (Learn how and when to remove this message)

PT Kalbe Farma Tbk

Company type	Public
Traded as	IDX: KLBF
Industry	Pharmaceuticals Healthcare
Founded	10 September 1966; 58 years ago (1966-09-10)
Headquarters	Jakarta, Indonesia
Area served	Worldwide
Key people	Vidjongtius (CEO) Bernadette Ruth Irawati Setiady (President)
Products	Drugs, energy drinks, milk, baby food, healthy drinks, herbal supplements and nutrition products
Revenue	Rp 26.261 trillion (2021)
Net income	Rp 3.208 trillion (2021)
Total assets	Rp 25.667 trillion (2021)
Total equity	Rp 21.365 trillion (2021)
Number of employees	16,235 (2021)
Subsidiaries	Bintang Toedjoe Kalbe Nutritionals Kalbe Genexine Biologics Innogene Kalbiotech Bifarma Adiluhung Kalbe International Innolab Sains Internasional Pharma Metric Labs Saka Farma Laboratories Dankos Farma Hexpharm Jaya Laboratories Hale International Finusolprima Farma Internasional Kalbe Milko Indonesia Enseval Putera Indogravure Kalbe Morinaga Kalbe Vision
Website	https://www.kalbe.co.id/

PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.^[1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).^[2]

Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.^{[citation needed]}

Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.